EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An ANXA11 P93S variant dysregulates TDP‐43 and causes corticobasal syndrome

Allison Snyder iD, Veronica H Ryan, James Hawrot, Sydney Lawton, Daniel M Ramos, Y Andy Qi, Kory R Johnson, Xylena Reed, Nicholas L Johnson, Aaron W Kollasch, Megan F Duffy, Lawren VandeVrede und 9 weitere

Alzheimer's & Dementia · 2024

DOI: 10.1002/alz.13915 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von Allison Snyder und 20 weiteren Autor:innen. Beteiligte Einrichtung: Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: DNA-Binding Proteins, Annexins. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH National Institute on Aging, NIDA NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Variants of uncertain significance (VUS) surged with affordable genetic testing, posing challenges for determining pathogenicity. We examine the pathogenicity of a novel VUS P93S in Annexin A11 (ANXA11) – an amyotrophic lateral sclerosis/frontotemporal dementia‐associated gene – in a corticobasal syndrome kindred. Established ANXA11 mutations cause ANXA11 aggregation, altered lysosomal‐RNA granule co‐trafficking, and transactive response DNA binding protein of 43 kDa (TDP‐43) mis‐localization. METHODS We described the clinical presentation and explored the phenotypic diversity of ANXA11 variants. P93S's effect on ANXA11 function and TDP‐43 biology was characterized in induced pluripotent stem cell‐derived neurons alongside multiomic neuronal and microglial profiling. RESULTS ANXA11 mutations were linked to corticobasal syndrome cases. P93S led to decreased lysosome colocalization, neuritic RNA, and nuclear TDP‐43 with cryptic exon expression. Multiomic microglial signatures implicated immune dysregulation and interferon signaling pathways. DISCUSSION This study establishes ANXA11 P93S pathogenicity, broadens the phenotypic spectrum of ANXA11 mutations, underscores neuronal and microglial dysfunction in ANXA11 pathophysiology, and demonstrates the potential of cellular models to determine variant pathogenicity. Highlights ANXA11 P93S is a pathogenic variant. Corticobasal syndrome is part of the ANXA11 phenotypic spectrum. Hybridization chain reaction fluorescence in situ hybridization (HCR FISH) is a new tool for the detection of cryptic exons due to TDP‐43‐related loss of splicing regulation. Microglial ANXA11 and related immune pathways are important drivers of disease. Cellular models are powerful tools for adjudicating variants of uncertain significance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA-Binding ProteinsAnnexinsHumansMaleMutationFemaleAmyotrophic Lateral SclerosisNeuronsFrontotemporal DementiaMiddle AgedAged

Stichwörter der Autor:innen

ANXA11TDP‐43corticobasal syndromevariant of uncertain significance

Substanzen

DNA-Binding ProteinsTARDBP protein, humanAnnexins

Autor:innen und Institutionen

  • Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • Center for Alzheimer's and Related Dementias, National Institutes of Health, Bethesda, Maryland, USA.
  • National Institute of General Medical Sciences, National Institutes of Health, Bethesda, Maryland, USA.
  • Intramural Bioinformatics Core, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • DataTecnica LLC, Washington, District of Columbia, USA.
  • Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Allison Snyder, Michael E Ward

Förderung

  • NIH National Institute on Aging
  • NIDA NIH HHS
  • NIA NIH HHS
  • NIH National Institute of Neurological Disorders and Stroke
  • NIGMS NIH HHS
  • NINDS NIH HHS
  • Global Brain Health Institute
  • NIH Undiagnosed Diseases Program, Undiagnosed Diseases Network

Zitieren

APA

Snyder, A., Ryan, V. H., Hawrot, J., Lawton, S., Ramos, D. M., Qi, Y. A., Johnson, K. R., Reed, X., Johnson, N. L., Kollasch, A. W., Duffy, M. F., VandeVrede, L., Cochran, J. N., Miller, B. L., Toro, C., Bielekova, B., Marks, D. S., Yokoyama, J. S., Kwan, J. Y., …, & Ward, M. E. (2024). An ANXA11 P93S variant dysregulates TDP‐43 and causes corticobasal syndrome. Alzheimer's & Dementia. https://doi.org/10.1002/alz.13915

Vancouver

Snyder A, Ryan VH, Hawrot J, Lawton S, Ramos DM, Qi YA, et al. An ANXA11 P93S variant dysregulates TDP‐43 and causes corticobasal syndrome. Alzheimer's & Dementia. 2024. doi:10.1002/alz.13915

BibTeX
@article{Snyder2024,
  author = {Snyder, Allison and Ryan, Veronica H and Hawrot, James and Lawton, Sydney and Ramos, Daniel M and Qi, Y Andy and Johnson, Kory R and Reed, Xylena and Johnson, Nicholas L and Kollasch, Aaron W and Duffy, Megan F and VandeVrede, Lawren and Cochran, J Nicholas and Miller, Bruce L and Toro, Camilo and Bielekova, Bibiana and Marks, Debora S and Yokoyama, Jennifer S and Kwan, Justin Y and Cookson, Mark R and Ward, Michael E},
  title = {An ANXA11 P93S variant dysregulates TDP‐43 and causes corticobasal syndrome},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  doi = {10.1002/alz.13915}
}
Kostenlos starten →